您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Chinese Acarbose market report

讯：

Research report of Chinese Acarbose market(API and Preparation)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$2,100 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com 


Brief introduction
    Acarbose is a pseudo-tetrasaccharide produced by biosynthesis, the 
first drug in the class called alpha-glucosidase inhibitors, aslo the
 first alpha-glucosidase inhibitor approved by US FDA, developed by
 Bayer AG。Acarbose was marketed in Germany firstly in July 1984, brand
 name Glucobay. Acarbose is the top 1 seller in the oral antidiabetic
 market in China. 

   The report (2006 edition) represents the import and export status of
 Acarbose API, production status of Acarbose API in China, sales
 analysis of Acarbose preparations in China, and the suggestions for
 marketing. In the report you can know the global output and market
 size of Acarbose API, market sizes of Acarbose API and preparations
 in China, the prices, the key manufacturers.

The table of contents
Overview of Acarbose market in China and the global marekt
1 Manufacturers of Acarbose API(Bulk drug)
  1.1 Bayer AG
  1.2 Chinese enterprises
    1.2.1 Sichuan Industrial Institute of Antibiotics Co. Ltd.
 (SIIA Co.Ltd.) 
    1.2.2 Hangzhou Huadong Medicine Group Co.,Ltd
    1.2.3 Zhejiang Zhebei Pharmaceutical Co.,Ltd.
    1.2.4 Zhejiang Hisun Pharmaceutical CO., Ltd
2 Import and export situation of Acarbose API
  2.1 Export statistic
  2.2 Import statistic
3 Sales analysis of Acarbose preparations in sample hospitals
  3.1 Market scale and market shares of different drugs in Chinese
 market of drugs for regulating blood sugar
  3.2 Market shares and growth trend of Acarbose preparations of
 different enterprises from 2002 to 2005
    3.2.1 Bayer AG
    3.2.2 Hangzhou Huadong Medicine Group Co.,Ltd
    3.2.3 Sichuan Baoguang Pharmaceutical Technology Co., LTD
  3.3 Sales analysis in sample cities
  3.4 Analysis of other competition breeds
    3.4.1 Voglibose
    3.4.2 Repaglinide
4 Suggestions for marketing